7808 related articles for article (PubMed ID: 20861923)
1. Induction characterization and targeting of human hematopoietic cancer stem cells.
Zhang M; Dias P; Minev B; Koka PS
J Stem Cells; 2010; 5(1):1-7. PubMed ID: 20861923
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitor-like state.
Kuranda K; Berthon C; Leprêtre F; Polakowska R; Jouy N; Quesnel B
J Cell Biochem; 2011 May; 112(5):1277-85. PubMed ID: 21308741
[TBL] [Abstract][Full Text] [Related]
3. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human hematopoietic stem cell populations.
Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
[TBL] [Abstract][Full Text] [Related]
5. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
7. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
Ramírez M; Rottman GA; Shultz LD; Civin CI
Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
[TBL] [Abstract][Full Text] [Related]
8. Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice.
Péault B; Weissman IL; Buckle AM; Tsukamoto A; Baum C
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):91-3. PubMed ID: 7685521
[TBL] [Abstract][Full Text] [Related]
9. Improved T and B cell recovery by the transfer of slowly dividing human hematopoietic stem cells.
Vitacolonna M; Schubert M; Herbert N; Taubert I; Singh R; Ho A; Zöller M
Leuk Res; 2010 May; 34(5):622-30. PubMed ID: 19906424
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells.
Hill B; Rozler E; Travis M; Chen S; Zannetino A; Simmons P; Galy A; Chen B; Hoffman R
Exp Hematol; 1996 Jul; 24(8):936-43. PubMed ID: 8690053
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
[TBL] [Abstract][Full Text] [Related]
13. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
[TBL] [Abstract][Full Text] [Related]
14. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34- fractions of Thy-1lowLin-/lowSca-1+ bone marrow cells.
Morel F; Galy A; Chen B; Szilvassy SJ
Exp Hematol; 1998 May; 26(5):440-8. PubMed ID: 9590662
[TBL] [Abstract][Full Text] [Related]
15. Identification of cancer stem cell markers in human malignant mesothelioma cells.
Ghani FI; Yamazaki H; Iwata S; Okamoto T; Aoe K; Okabe K; Mimura Y; Fujimoto N; Kishimoto T; Yamada T; Xu CW; Morimoto C
Biochem Biophys Res Commun; 2011 Jan; 404(2):735-42. PubMed ID: 21163253
[TBL] [Abstract][Full Text] [Related]
16. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
Novelli EM; Ramírez M; Leung W; Civin CI
Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459
[TBL] [Abstract][Full Text] [Related]
17. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC
Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
[TBL] [Abstract][Full Text] [Related]
19. Pluripotential hematopoietic stem cells in post-5-fluorouracil murine bone marrow express the Thy-1 antigen.
Williams DE; Boswell HS; Floyd AD; Broxmeyer HE
J Immunol; 1985 Aug; 135(2):1004-11. PubMed ID: 2861227
[TBL] [Abstract][Full Text] [Related]
20. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
